VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Aug 14, 2007 -- Chemokine Therapeutics Corp. (the “Company”) (Toronto:CTI.TO - News)(OTC BB:CHKT.OB - News), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced the financial and operating results of the second quarter ended June 30, 2007.
